Long-Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial

Clare Tanton,Helen A. Weiss,Mary Rusizoka,Jérôme Legoff,John Changalucha,Kathy Baisley,Kokugonza Mugeye,Dean Everett,Laurent Bélec,Tim Clayton,David A. Ross,Richard Hayes,Deborah Watson-Jones

Long-Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial

2010

Clare Tanton
Helen A. Weiss
Mary Rusizoka
Jérôme Legoff
John Changalucha
Kathy Baisley
Kokugonza Mugeye
Dean Everett
Laurent Bélec
Tim Clayton
David A. Ross
Richard Hayes
Deborah Watson-Jones

Background Herpes simplex virus (HSV) suppressive therapy reduces genital and plasma HIV-1 RNA over periods up to three months but the longer-term effect is unknown.

Keywords:

Herpes Genitalis
Virus
Virology
Aciclovir
Randomized controlled trial
Immunology
Placebo-controlled study
Herpes simplex virus
Pharmacotherapy
Medicine
Lentivirus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations